Mar 21 |
Bolt Biotherapeutics GAAP EPS of -$0.47 in-line, revenue of $2.1M beats by $0.31M
|
Mar 21 |
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
|
Feb 27 |
Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
|
Dec 21 |
Pacira Appoints Frank D. Lee as Chief Executive Officer
|
Dec 5 |
Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
|
Nov 20 |
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?
|
Nov 9 |
Bolt Biotherapeutics GAAP EPS of -$0.43 beats by $0.03, revenue of $2.5M beats by $0.74M
|
Nov 9 |
Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
|
Nov 7 |
Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
|
Oct 24 |
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
|